- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,930 | 09.07.24 21:55:16 | +0,150 | +0,12% | 125,930 | 125,950 | 126,800 | 125,780 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 91,845 | 09.07.24 21:54:11 | +4,965 | +5,71% | 91,760 | 91,900 | 87,780 | 86,880 |
